Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain

NCT03245008 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

626

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee / Osteoarthritis, Hip

Interventions

DRUG: MT-5547
DRUG: MT-5547-matching placebo

Sponsor

Tanabe Pharma Corporation